Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buparid/PARI SINUS vs Budes Nasal Spray in Chronic Rhinosinusitis
NCT01955980Phase 2Completed
- Sponsor
- PARI Pharma
- Start
- Oct 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EPI-EE in chronic rhinosinusitis (CRS), sponsored by PARI Pharma. Started Oct 2015; status: completed.
02
Drugs
EPI-EE
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT01955980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01955980.